| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Biochemistry and Biophysics, Loyola University of Chicago, Stritch School of Medicine, Maywood, Illinois 60153 [F. Q., A. S. B., A. F.], and the Department of Biochemistry and Molecular Biology and the Howard Hughes Medical Institute, The University of Chicago, Chicago, Illinois 60637 [D. F. S., S. J. C.]
The relative levels of mRNAs for cathepsins B, D, H, L, and S in eight normal murine tissues and three murine melanoma variants, B16-F1, B16-F10, and B16a, have been analyzed by RNA dot blot and densitometry. A direct correlation was observed between the levels of cathepsin B mRNA and the metastatic potentials of these three melanoma variants. The relative amount of cathepsin B mRNA in B16a, which is the melanoma variant with the highest metastatic potential, was at least 3 times greater than that found in any of the normal murine tissues surveyed. Similar results were obtained in analyses of either solid tumors or of cultures of tumor cells, confirming that the tumor cells themselves were the source for the elevated expression of cathepsin B mRNA. Northern blot analysis revealed the presence of three cathepsin B transcripts of 5.0, 4.0, and 2.2 kilobases in the melanoma variants, while only the 2.2-kilobase transcript was seen in the normal murine tissues. Concurrently with the mRNA analysis, enzyme assays for cathepsin B activity were also performed using synthetic peptide substrates. The assays revealed increased cathepsin B activities in the melanoma variants, corresponding well with the increased cathepsin B mRNA levels, and in addition demonstrated that all three of the melanoma variants secreted a latent form of cathepsin B into conditioned medium, which could be activated by limited proteolysis with pepsin. The levels of the latent enzyme released by the murine melanoma variants correlated well with the levels of cathepsin B mRNA and with the metastatic potentials as determined by spontaneous metastasis from a s.c. site.
1 Supported in part by NIH Grant CA44659 (A. S. B.), Potts Foundation Grant 842-01 (A. F.), and NIH Grants DK13914 and DK20595.
2 To whom requests for reprints should be addressed.
Received 2/16/89. Revised 5/11/89. Accepted 5/17/89.
This article has been cited by other articles:
![]() |
W. E. G. Muller, A. Boreiko, U. Schlossmacher, X. Wang, C. Eckert, K. Kropf, J. Li, and H. C. Schroder Identification of a silicatein(-related) protease in the giant spicules of the deep-sea hexactinellid Monorhaphis chuni J. Exp. Biol., February 1, 2008; 211(3): 300 - 309. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Im, A. Venkatakrishnan, and A. Kazlauskas Cathepsin B Regulates the Intrinsic Angiogenic Threshold of Endothelial Cells Mol. Biol. Cell, August 1, 2005; 16(8): 3488 - 3500. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Fujita, M. Koike, M. Fujita, Y. Sakamoto, S. Okuno, T. Kawaguchi, S. Yano, T. Yano, S. Kiuchi, T. Fujiwara, et al. MEN4901/T-0128, a New Camptothecin Derivative-Carboxymethyldextran Conjugate, Has Potent Antitumor Activities in a Panel of Human Tumor Xenografts in Nude Mice Clin. Cancer Res., February 15, 2005; 11(4): 1650 - 1657. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Nishimura, H. Naruishi, K. Naruishi, T. Yamada, J. Sasaki, C. Peters, Y. Uchiyama, and Y. Murayama Cathepsin-L, a Key Molecule in the Pathogenesis of Drug-Induced and I-Cell Disease-Mediated Gingival Overgrowth: A Study with Cathepsin-L-Deficient Mice Am. J. Pathol., December 1, 2002; 161(6): 2047 - 2052. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.P. Dickinson CYSTEINE PEPTIDASES OF MAMMALS: THEIR BIOLOGICAL ROLES AND POTENTIAL EFFECTS IN THE ORAL CAVITY AND OTHER TISSUES IN HEALTH AND DISEASE Critical Reviews in Oral Biology & Medicine, May 1, 2002; 13(3): 238 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Szpaderska and A. Frankfater An Intracellular Form of Cathepsin B Contributes to Invasiveness in Cancer Cancer Res., April 1, 2001; 61(8): 3493 - 3500. [Abstract] [Full Text] |
||||
![]() |
M. T. Moran, J. P. Schofield, A. R. Hayman, G.-P. Shi, E. Young, and T. M. Cox Pathologic gene expression in Gaucher disease: up-regulation of cysteine proteinases including osteoclastic cathepsin K Blood, September 1, 2000; 96(5): 1969 - 1978. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Nishimura, K. Naruishi, H. Yamada, T. Kono, S. Takashiba, and Y. Murayama High Glucose Suppresses Cathepsin Activity in Periodontal-ligament-derived Fibroblastic Cells Journal of Dental Research, August 1, 2000; 79(8): 1614 - 1617. [Abstract] [PDF] |
||||
![]() |
F. Denis, N. H. Shoukry, M. Delcourt, J. Thibodeau, N. Labrecque, H. McGrath, J. S. Munzer, N. G. Seidah, and R.-P. Sékaly Alternative Proteolytic Processing of Mouse Mammary Tumor Virus Superantigens J. Virol., April 1, 2000; 74(7): 3067 - 3073. [Abstract] [Full Text] |
||||
![]() |
D. Mruk, C.-H. Cheng, Y.-H. Cheng, M.-y. Mo, J. Grima, B. Silvestrini, W. M. Lee, and C. Y. Cheng Rat Testicular Extracellular Superoxide Dismutase: Its Purification, Cellular Distribution, and Regulation Biol Reprod, August 1, 1998; 59(2): 298 - 308. [Abstract] [Full Text] |
||||
![]() |
S. Mehtani, Q. Gong, J. Panella, S. Subbiah, D. M. Peffley, and A. Frankfater In Vivo Expression of an Alternatively Spliced Human Tumor Message That Encodes a Truncated Form of Cathepsin B. SUBCELLULAR DISTRIBUTION OF THE TRUNCATED ENZYME IN COS CELLS J. Biol. Chem., May 22, 1998; 273(21): 13236 - 13244. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Dandoy-Dron, F. Guillo, L. Benboudjema, J.-P. Deslys, C. Lasmezas, D. Dormont, M. G. Tovey, and M. Dron Gene Expression in Scrapie. CLONING OF A NEW SCRAPIE-RESPONSIVE GENE AND THE IDENTIFICATION OF INCREASED LEVELS OF SEVEN OTHER mRNA TRANSCRIPTS J. Biol. Chem., March 27, 1998; 273(13): 7691 - 7697. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Afonso, L Romagnano, and B Babiarz The expression and function of cystatin C and cathepsin B and cathepsin L during mouse embryo implantation and placentation Development, January 9, 1997; 124(17): 3415 - 3425. [Abstract] [PDF] |
||||
![]() |
B. Sloane, K Moin, M Sameni, L. Tait, J Rozhin, and G Ziegler Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene J. Cell Sci., January 2, 1994; 107(2): 373 - 384. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |